Alchemia: First granting of antibody patents
Key patent granted in Japan
28-Jul-2011 -
Alchemia Limited has been granted a new Japanese patent covering its HyACT® platform, which has been shown to increase the effectiveness of cancer drugs. Alchemia’s lead program using this technology, HA-Irinotecan, is about to enter a pivotal Phase III trial for the treatment of colorectal ...
antibodies
colorectal cancer
Japan
+1